{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:59:54Z","timestamp":1791259194867,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:00:00Z","timestamp":1605052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:sec>\n<jats:title>Purpose<\/jats:title>\n<jats:p>To report the prevalence of uveal melanoma in a Hospital database in Brazil over the period of 16\u00a0years (2000 to 2016).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Design<\/jats:title>\n<jats:p>Descriptive epidemiological study evaluating the Brazilian Hospital Based Cancer Registries.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Participants\/methods<\/jats:title>\n<jats:p>Uveal melanomas were identified based on ICD-O-3 codes C69.3 [choroid], C69.4 [ciliary body and iris], and C69.2 [retina]) derived from the Integrator Registry database. Kolmogorov\u2013Smirnov Test was used for evaluation of normality of data, t-test and Chi square were used for categorical and continuous variables respectively using SPSS Software.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Main outcome measures<\/jats:title>\n<jats:p>Age, sex, education, regional distribution, clinical staging at the diagnosis, time from diagnosis to treatment (\u2264\u200960\u00a0days versus\u2009&gt;\u200960\u00a0days) and first-course therapy (surgery, chemotherapy, radiotherapy or a combination of such).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>There were 2166 cases of uveal melanoma representing 5.4% of all cases of melanoma. Histological confirmation of uveal melanoma was available in all cases. Higher prevalence of 1139 cases (52.6%) in women than 1027 cases (47.4%) in men was observed. Age distribution revealed 1411 cases (65.1%) in the group between 41 and 69\u00a0years old. A total of 429 (19.8%) patients were classified as initial disease and 334 (15.4%) as advanced (regional or distant metastases). Staging as initial disease was more frequent (113\u201324.8%) in patients with\u2009&gt;\u20098 school years than in patients with\u2009&lt;\u20098 school years (179\u201317.6%) reflecting disparities in healthcare access between those two populations. No difference was noticed in terms of diagnosis, staging and treatment after the Brazilian \u201c60\u00a0days law\u201d (Federal Law 12.732\/12) came into effect in 2013 regulating the maximum period that a patient with cancer has to wait until start the treatment.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Epidemiological data is critical for planning early treatment strategies and allocating medical resources. This study intended to understand the characteristics of uveal melanoma in Brazil.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s40942-020-00261-w","type":"journal-article","created":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T14:03:09Z","timestamp":1605103389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Epidemiology of uveal melanoma in Brazil"],"prefix":"10.1186","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8195-0136","authenticated-orcid":false,"given":"Evandro","family":"Lucena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Cohen","family":"Goldemberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Claudio Santos","family":"Thuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreia Cristina","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,11]]},"reference":[{"issue":"5","key":"261_CR1","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/cncr.20866","volume":"103","author":"CC McLaughlin","year":"2005","unstructured":"McLaughlin CC, Wu XC, Jemal A, Martin HJ, Roche LM, Chen VW. Incidence of noncutaneous melanomas in the U.S. Cancer. 2005;103(5):1000\u20137.","journal-title":"Cancer."},{"issue":"15","key":"261_CR2","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1002\/cncr.29727","volume":"122","author":"C Chattopadhyay","year":"2016","unstructured":"Chattopadhyay C, Kim DW, Gombos DS, Oba J, Qin Y, Williams MD, et al. Uveal melanoma: From diagnosis to treatment and the science in between. Cancer. 2016;122(15):2299\u2013312.","journal-title":"Cancer"},{"key":"261_CR3","doi-asserted-by":"publisher","unstructured":"Singh AD, Turell ME, Topham AK. Uveal melanoma: Trends in incidence, treatment, and survival. Ophthalmology [Internet]. 2011;118(9):1881\u20135. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1016\/j.ophtha.2011.01.040","DOI":"10.1016\/j.ophtha.2011.01.040"},{"issue":"1","key":"261_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ohc.2004.07.002","volume":"18","author":"AD Singh","year":"2005","unstructured":"Singh AD, Bergman L, Seregard S. Uveal melanoma: Epidemiologic aspects. Ophthalmol Clin North Am. 2005;18(1):75\u201384.","journal-title":"Ophthalmol Clin North Am"},{"issue":"4","key":"261_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0039-6257(88)90173-7","volume":"32","author":"KM Egan","year":"1988","unstructured":"Egan KM, Seddon JM, Glynn RJ, Gragoudas ES, Albert DM. Epidemiologic aspects of uveal melanoma. Surv Ophthalmol. 1988;32(4):239\u201351.","journal-title":"Surv Ophthalmol."},{"issue":"6","key":"261_CR6","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1097\/CMR.0000000000000511","volume":"28","author":"AC De Melo","year":"2018","unstructured":"De Melo AC, Wainstein AJA, Buzaid AC, Thuler LCS. Melanoma signature in Brazil: Epidemiology, incidence, mortality, and trend lessons from a continental mixed population country in the past 15 years. Melanoma Res. 2018;28(6):629\u201336.","journal-title":"Melanoma Res"},{"issue":"1","key":"261_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-57253-6","volume":"10","author":"D Cohen Goldemberg","year":"2020","unstructured":"Cohen Goldemberg D, de Melo AC, de Melo Pino LC, Thuler LCS. Epidemiological profile of mucosal melanoma in Brazil. Sci Rep. 2020;10(1):1\u20137.","journal-title":"Sci Rep"},{"key":"261_CR8","unstructured":"Instituto Nacional do C\u00e2ncer. Estimate\/2020 - Cancer incidence in Brazil. 2020. 300 p. https:\/\/www.inca.gov.br\/sites\/ufu.sti.inca.local\/files\/\/media\/document\/\/estimativa-2020-incidencia-de-cancer-no-brasil.pdf"},{"issue":"1","key":"261_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1590\/S1516-31802008000100008","volume":"126","author":"NM Ferrari","year":"2008","unstructured":"Ferrari NM, Muller H, Ribeiro M, Maia M, Sanches JA. Cutaneous melanoma: Descriptive epidemiological study. Sao Paulo Med J. 2008;126(1):41\u20137.","journal-title":"Sao Paulo Med J"},{"issue":"5","key":"261_CR10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1590\/S1020-49892011001100005","volume":"30","author":"RA Schmerling","year":"2011","unstructured":"Schmerling RA, Loria D, Cinat G, Ramos WE, Cardona AF, S\u00e1nchez JL, et al. Cutaneous melanoma in Latin America: the need for more data. Rev Panam Salud Publica. 2011;30(5):431\u20138.","journal-title":"Rev Panam Salud Publica."},{"issue":"1","key":"261_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ohc.2004.08.004","volume":"18","author":"AD Singh","year":"2005","unstructured":"Singh AD, Damato B, Howard P, Harbour JW. Uveal melanoma: genetic aspects. Ophthalmol Clin North Am. 2005;18(1):85\u201397.","journal-title":"Ophthalmol Clin North Am"},{"key":"261_CR12","first-page":"1","volume":"1","author":"MH Abdel-Rahman","year":"2020","unstructured":"Abdel-Rahman MH, Sample KM, Pilarski R, Walsh T, Grosel T, Kinnamon D, et al. Whole exome sequencing identifies candidate genes associated with hereditary predisposition to uveal melanoma. Ophthalmology. 2020;1:1\u201311.","journal-title":"Ophthalmology."},{"key":"261_CR13","doi-asserted-by":"crossref","unstructured":"Zimmehman LE, McLean IW. Do Growth and Onset of Symptoms of Uveal Melanomas Indicate Subclinical Metastasis? Ophthalmology [Internet]. 1984;91(6):685\u201391. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0161642084342439","DOI":"10.1016\/S0161-6420(84)34243-9"},{"key":"261_CR14","doi-asserted-by":"publisher","unstructured":"Damato B. Does ocular treatment of uveal melanoma influence survival? Br J Cancer [Internet]. 2010;103(3):285\u201390. Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1038\/sj.bjc.6605765","DOI":"10.1038\/sj.bjc.6605765"},{"issue":"4","key":"261_CR15","first-page":"377","volume":"57","author":"A Furdova","year":"2010","unstructured":"Furdova A, Slezak P, Chorvath M, Waczulikova I, Sramka M, Kralik G. No differences in outcome between radical surgical treatment (enucleation) and stereotactic radiosurgery in patients with posterior uveal melanoma. Neoplasma. 2010;57(4):377\u201381.","journal-title":"Neoplasma"},{"key":"261_CR16","doi-asserted-by":"crossref","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The Eighth Edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139.","DOI":"10.3322\/caac.21388"},{"key":"261_CR17","unstructured":"IBGE. Censo Demogr\u00e1fico 2010, Caracter\u00edsticas da Popula\u00e7\u00e3o e dos Domic\u00edlios, Resultados do Universo. https:\/\/biblioteca.ibge.gov.br\/visualizacao\/periodicos\/93\/cd_2010_caracteristicas_populacao_domicilios.pdf. 2011."},{"key":"261_CR18","doi-asserted-by":"crossref","unstructured":"Xu Y, Lou L, Wang Y, Miao Q, Jin K, Chen M, et al. Epidemiological study of uveal melanoma from US surveillance, epidemiology, and end results program (2010\u20132015). J Ophthalmol. 2020;2020.","DOI":"10.1155\/2020\/3614039"},{"key":"261_CR19","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1016\/j.ophtha.2007.01.032","volume":"114","author":"G Virgili","year":"2007","unstructured":"Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E, Lutz JM, Paci E. Incidence of Uveal Melanoma in Europe. Ophthalmology. 2007;114:2309\u201315.","journal-title":"Ophthalmology."},{"issue":"10","key":"261_CR20","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.2147\/OPTH.S113623","volume":"25","author":"K Mahendraraj","year":"2016","unstructured":"Mahendraraj K, Lau CSM, Lee I, Chamberlain RS. Trends in incidence, survival, and management of uveal melanoma: A population-based study of 7,516 patients from the surveillance, epidemiology, and end results database (1973\u20132012). Clin Ophthalmol. 2016;25(10):2113\u20139.","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"261_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.5935\/0004-2749.20190024","volume":"82","author":"S Cohen","year":"2019","unstructured":"Cohen S, Pretyman CS, Sant\u2019ana R, Singh N, Morales M, Belfort RN, et al. The Amazon Ocular Oncology Center: The first three years Centro de Oncologia Ocular do Amazonas: primeiros tr\u00eas anos. Arq Bras Oftalmol. 2019;82(2):107\u201317. https:\/\/doi.org\/10.5935\/0004-2749.20190024.","journal-title":"Arq Bras Oftalmol."},{"issue":"1","key":"261_CR22","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2174\/1874210601307010140","volume":"7","author":"D Sirianni","year":"2013","unstructured":"Sirianni D, Leles CR, Mendon\u00e7a EF. A 12-year retrospective survey of management of patients with malignant neoplasms in the orbital cavity in a Brazilian Cancer Hospital. Open Dent J. 2013;7(1):140\u20135.","journal-title":"Open Dent J"},{"issue":"2","key":"261_CR23","first-page":"111","volume":"114","author":"M Mierzwa-Dobranowska","year":"2012","unstructured":"Mierzwa-Dobranowska M, Romanowska-Dixon B. Assessment of the influence of one\u2019s education on early diagnosis of multiple primary cancer in patients with uveal melanoma. Klin Oczna. 2012a;114(2):111\u20134.","journal-title":"Klin Oczna"},{"issue":"6","key":"261_CR24","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3109\/09286586.2013.844842","volume":"20","author":"M Zinkhan","year":"2013","unstructured":"Zinkhan M, Stang A, J\u00f6ckel KH, Marr A, Bornfeld N, Schmidt-Pokrzywniak A. Having children, social characteristics, smoking and the risk of uveal melanoma: A case-control study. Ophthalmic Epidemiol. 2013;20(6):360\u20138.","journal-title":"Ophthalmic Epidemiol"},{"key":"261_CR25","doi-asserted-by":"crossref","unstructured":"Stang A, Ahrens W, Anastassiou G, J\u00f6ckel KH. Phenotypical characteristics, lifestyle, social class and uveal melanoma. 2003.","DOI":"10.1076\/opep.10.5.293.17319"},{"issue":"2","key":"261_CR26","first-page":"107","volume":"114","author":"M Mierzwa-Dobranowska","year":"2012","unstructured":"Mierzwa-Dobranowska M, Romanowska-Dixon B. One\u2019s location of residence as an important factor related to the occurrence of multiple primary cancer among patients with uveal melanoma. Klin Oczna. 2012b;114(2):107\u201310.","journal-title":"Klin Oczna"},{"issue":"3","key":"261_CR27","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.3802\/jgo.2018.29.e44","volume":"29","author":"E Paulino","year":"2018","unstructured":"Paulino E, de Melo AC, Nogueira-Rodrigues A, Thuler LCS. Gynecologic cancer in Brazil and the law of sixty days. J Gynecol Oncol. 2018;29(3):2014\u20137.","journal-title":"J Gynecol Oncol"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-020-00261-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40942-020-00261-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-020-00261-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T14:35:04Z","timestamp":1605105304000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-020-00261-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,11]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["261"],"URL":"https:\/\/doi.org\/10.1186\/s40942-020-00261-w","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,11]]},"assertion":[{"value":"2 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics in Human Research Committee of the National Cancer Institute of Brazil (INCA), Rio de Janeiro, Brazil (reference number 128\/11, CAAE \u2013 0104.0.007.000-11) and is in accordance with the Good Clinical Practice Guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No conflicting relationship exists for any author.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}